V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10003105 | 10001994 | 0 | 70 | Curative (C) | 2013-03-15 | 2013-03-15 | CVP R | 2 | N | 10461032 | CVP R |
| 10003106 | 10001995 | 1.6 | 53.5 | Palliative (P) | 2017-06-29 | 2017-07-14 | Cisplatin + Pemetrexed | 2 | N | 10461045 | CISPLATIN + PEMETREXED |
| 10003107 | 10001996 | 1.56 | 63.9 | Palliative (P) | 2015-08-07 | 2015-08-12 | Cisplatin + Pemetrexed | 02 | N | 10461070 | CISPLATIN + PEMETREXED |
| 10003108 | 10001996 | 1.88 | null | Palliative (P) | 2015-08-01 | 2015-08-01 | Cisplatin + Pemetrexed | N | N | 10461070 | CISPLATIN + PEMETREXED |
| 10003109 | 10001996 | 1.7 | 48 | Palliative (P) | 2018-07-17 | 2018-07-18 | Enzalutamide | 99 | null | 10461070 | ENZALUTAMIDE |
| 10003110 | 10001997 | 1.75 | 99.9 | Adjuvant (A) | 2017-01-05 | 2017-01-05 | Cisplatin + Vinorelbine (PO) | 02 | N | 10461148 | CISPLATIN + VINORELBINE |
| 10003111 | 10001998 | 1.59 | 69 | Palliative (P) | null | 2017-12-22 | EOX | N | N | 10461176 | EOX |
| 10003112 | 10001999 | 0 | 82.5 | Palliative (P) | 2017-10-14 | 2017-10-24 | EOX | N | N | 10461202 | EOX |
| 10003113 | 10002000 | 1.67 | 91.5 | Neo-adjuvant (N) | 2017-06-04 | 2017-06-04 | ECX | N | N | 10461210 | ECX |
| 10003114 | 10002001 | 1.57 | 46.6 | Adjuvant (A) | null | 2016-04-13 | Hydroxycarbamide | N | N | 10461212 | HYDROXYCARBAMIDE |
| 10003115 | 10002002 | 1.68 | 75.5 | Disease modification (D) | 2018-03-07 | 2018-03-11 | Hydroxycarbamide | N | N | 10461235 | HYDROXYCARBAMIDE |
| 10003116 | 10002003 | 1.63 | 70.1 | Curative (C) | 2016-03-05 | 2016-03-17 | CVP R | N | N | 10461240 | CVP R |
| 10003117 | 10002003 | 0 | 0 | Neo-adjuvant (N) | 2018-03-19 | 2018-04-01 | ECX | 02 | N | 10461240 | ECX |
| 10003118 | 10002003 | 1.56 | 50.8 | Neo-adjuvant (N) | 2015-02-24 | 2015-03-01 | ECX | N | N | 10461240 | ECX |
| 10003119 | 10002003 | 1.56 | null | Palliative (P) | 2015-05-29 | 2015-05-30 | PEMBROLIZUMAB | 2 | N | 10461240 | PEMBROLIZUMAB |
| 10003120 | 10002004 | 1.72 | null | Palliative (P) | 2016-06-10 | 2016-06-10 | Carboplatin + Vinorelbine IV | 2 | N | 10461379 | CARBOPLATIN + VINORELBINE |
| 10003121 | 10002005 | 1.79 | 67.8 | Disease modification (D) | 2017-02-09 | 2017-02-09 | GEMCITABINE | N | N | 10461390 | GEMCITABINE |
| 10003122 | 10008786 | 0 | 73.1 | Palliative (P) | 2018-02-12 | 2018-02-21 | Gemcitabine 1000mg/m2 D1 8 15 | 02 | N | 10461484 | GEMCITABINE |
| 10003123 | 10002006 | 1.66 | null | Palliative (P) | 2017-07-07 | 2017-07-16 | PEMBROLIZUMAB | 02 | N | 10461526 | PEMBROLIZUMAB |
| 10003124 | 10002006 | 1.66 | 49 | Palliative (P) | 2017-07-21 | 2017-07-23 | PEMBROLIZUMAB | 02 | N | 10461526 | PEMBROLIZUMAB |
| 10003125 | 10002006 | 1.61 | 68.8 | Disease modification (D) | 2013-12-11 | 2013-12-23 | Hydroxycarbamide | N | N | 10461526 | HYDROXYCARBAMIDE |
| 10003126 | 10002007 | 1.53 | null | Curative (C) | 2017-09-14 | 2017-11-24 | CVP R | N | N | 10461642 | CVP R |
| 10003127 | 10002008 | 1.84 | 77.2 | Disease modification (D) | 2017-11-08 | 2017-11-08 | Hydroxycarbamide | 02 | N | 10461654 | HYDROXYCARBAMIDE |
| 10003128 | 10002008 | 1.68 | 45 | null | 2017-01-24 | 2017-02-21 | Gemcitabine weekly | 02 | N | 10461654 | GEMCITABINE |
| 10003129 | 10002009 | null | 60 | Disease modification (D) | 2019-04-25 | 2019-05-01 | Rituximab | N | N | 10461710 | RITUXIMAB |
| 10003130 | 10006356 | 1.58 | 75.6 | Palliative (P) | null | 2016-08-01 | Hydroxycarbamide | N | N | 10461730 | HYDROXYCARBAMIDE |
| 10003131 | 10006356 | null | 60 | Palliative (P) | 2013-12-05 | 2013-12-05 | Gemcitabine 1000mg/m2 D1 8 15 | N | N | 10461730 | GEMCITABINE |
| 10003132 | 10002010 | null | 67.4 | Palliative (P) | 2017-06-02 | 2017-06-15 | PEMBROLIZUMAB | 02 | N | 10461805 | PEMBROLIZUMAB |
| 10003133 | 10002010 | 1.52 | 66.5 | Disease modification (D) | 2015-04-14 | 2015-04-23 | Hydroxycarbamide | N | N | 10461805 | HYDROXYCARBAMIDE |
| 10003134 | 10002010 | 1.66 | null | Not known (9) | 2018-10-23 | 2018-10-23 | EOX | 02 | N | 10461805 | EOX |
| 10003135 | 10002011 | 1.66 | 67.8 | Adjuvant (A) | 2016-04-22 | 2016-04-27 | Cisplatin + Vinorelbine (PO) | 02 | N | 10462077 | CISPLATIN + VINORELBINE |
| 10003136 | 10002012 | null | 74.8 | Palliative (P) | 2017-03-19 | 2017-03-29 | Enzalutamide | 02 | N | 10462143 | ENZALUTAMIDE |
| 10003137 | 10002013 | 1.71 | 91.9 | Palliative (P) | null | 2016-05-19 | Gemcitabine weekly | N | N | 10462151 | GEMCITABINE |
| 10003138 | 10002014 | 1.69 | 100.8 | null | 2015-11-20 | 2015-11-20 | Rituximab | N | null | 10462205 | RITUXIMAB |
| 10003139 | 10002014 | 1.7 | 93.3 | Palliative (P) | 2018-02-08 | 2018-02-17 | ECX | 02 | N | 10462205 | ECX |
| 10003140 | 10002014 | 1.81 | 92.5 | Palliative (P) | 2013-12-30 | 2014-01-17 | EOX | 02 | N | 10462205 | EOX |
| 10003141 | 10002014 | 0 | null | Neo-adjuvant (N) | 2015-10-08 | 2015-10-16 | ECX | N | N | 10462205 | ECX |
| 10003142 | 10002014 | 1.56 | 77.2 | Palliative (P) | 2014-12-11 | 2014-12-21 | Cisplatin + Vinorelbine (IV) | 2 | N | 10462205 | CISPLATIN + VINORELBINE |
| 10003143 | 10002014 | 1.8 | 73 | Palliative (P) | 2019-06-08 | 2019-07-05 | CVP R | 2 | N | 10462205 | CVP R |
| 10003144 | 10002014 | null | 0 | Palliative (P) | 2013-03-31 | 2013-04-22 | Cisplatin + Pemetrexed | null | N | 10462205 | CISPLATIN + PEMETREXED |
| 10003145 | 10002015 | null | 49.3 | Neo-adjuvant (N) | 2016-06-11 | 2016-06-11 | ECX | null | N | 10462614 | ECX |
| 10003146 | 10002016 | null | 67.7 | null | 2016-09-26 | 2016-10-16 | Cisplatin + Pemetrexed | N | N | 10462676 | CISPLATIN + PEMETREXED |
| 10003147 | 10002017 | null | null | Adjuvant (A) | 2017-04-03 | 2017-04-03 | Cisplatin + Vinorelbine (IV) | N | N | 10462780 | CISPLATIN + VINORELBINE |
| 10003148 | 10002018 | 1.82 | 76.4 | Disease modification (D) | 2018-07-13 | 2018-07-15 | Hydroxycarbamide | N | N | 10462823 | HYDROXYCARBAMIDE |
| 10003149 | 10002019 | 0 | 76 | Adjuvant (A) | 2017-12-07 | 2017-12-08 | CISPLATIN + VINORELBINE | 02 | N | 10462841 | CISPLATIN + VINORELBINE |
| 10003150 | 10002019 | 1.58 | null | Palliative (P) | 2017-11-12 | 2017-11-29 | Carboplatin + Vinorelbine Oral | 02 | N | 10462841 | CARBOPLATIN + VINORELBINE |
| 10003151 | 10002019 | 1.57 | 63.9 | Palliative (P) | 2019-01-31 | 2019-02-07 | PEMBROLIZUMAB | 02 | N | 10462841 | PEMBROLIZUMAB |
| 10003152 | 10002019 | 1.43 | 61.4 | Disease modification (D) | 2017-07-08 | 2017-07-19 | Enzalutamide | 99 | null | 10462841 | ENZALUTAMIDE |
| 10003153 | 10002019 | null | 0 | Curative (C) | 2014-01-23 | 2014-01-23 | CVP R | N | N | 10462841 | CVP R |
| 10003154 | 10002019 | 1.8 | 48.8 | Not known (9) | 2014-08-12 | 2014-08-12 | Trial Unspecified | Y | N | 10462841 | TRIAL |